Status and phase
Conditions
Treatments
About
The trial consists of Stage 1 (including dose escalation and dose expansion) and Stage 2 (proof-of-concept study). Among them, Stage 2 adopts a randomized, controlled, open-label, and multicenter design.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
350 participants in 2 patient groups
Loading...
Central trial contact
Clinical Trials Information Group officer
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal